European Commission launches new Biotech and Biomanufacturing Hub
February 4, 2025 | by Rishi


Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, an advisor to MedTech suppliers, chair of the Urology Trade Association, and governor of the Anscombe Bioethics Centre, flags a new EU resource for biotech start-ups.
The European Commission has launched a new Biotech and Biomanufacturing Hub to support companies, particularly start-ups and SMEs, in bringing innovative products to the EU market and increasing their competitiveness.
The Hub will also help companies identify the support available to them at EU level to help them to expand and grow.
The Biotech and Biomanufacturing Hub sets out in all EU languages:
- The sources of EU funding available to biotech and biomanufacturing companies;
- The research infrastructures that can support biotech or biomanufacturing Research & Development;
- The resources available to help biotech or biomanufacturing businesses to scale up, including networks, pilot and testing facilities and market insights;
- The intellectual property protection to which innovative companies are entitled;
- The processes for authorising new biotech products and the support offered to applicants throughout these processes;
- The rules and requirements with which companies must comply when developing and marketing biotech products in the EU.
The Hub will serve as an operational tool for easy and accessible information on the relevant EU legislation, financing opportunities and business support networks, such as the Enterprise Europe Network and European Cluster Collaboration Platform.
Biotechnology is one of the fastest growing innovative industries in the EU, which has the potential to revolutionise health, agriculture, food and feed and industry in Europe over the coming years. It is seen as key to building a more competitive, innovative and resilient EU, that succeeds in its green and digital transitions.
The new Hub was promised in the Commission’s 2024 Strategy to boost biotechnology and biomanufacturing in the EU.
The Author used AI in preparing this article. Comments upon or questions about this article can be addressed to chris.whitehouse@whitehousecomms.com.
Related
RELATED POSTS
View all